Spontaneous bacterial peritonitis outcome and ceftriaxone dosage data

Anonymized outcome data from medical records of patients treated with ceftriaxone for spontaneous bacterial peritonitis at the Beth Israel Deaconess Medical Center, Boston, USA, between January 2003 and December 2011. Exclusion criteria from dataset were: <250 neutrophils in ascites, prior liver transplant, evidence of intra-abdominal source of infection (abscess, perforation, recent (within 2 weeks) intra-abdominal surgery), peritoneal dialysis and documentation of a secondary infection (urinary tract infection, pneumonia, blood stream infection, cellulitis, meningitis) for which ceftriaxone was started prior to peritoneal fluid collection.